TEN-K Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ten-k, and what generic alternatives are available?
Ten-k is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in TEN-K is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-eight suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ten-k
A generic version of TEN-K was approved as potassium chloride by ACTAVIS LABS FL INC on April 10th, 2002.
Summary for TEN-K
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 314 |
| Patent Applications: | 300 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TEN-K at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TEN-K
US Patents and Regulatory Information for TEN-K
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | TEN-K | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 019381-001 | Apr 16, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
